Skip to main content

Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study

The Original Article was published on 09 December 2020

Correction to: Trials (2020) 21:1005

https://doi.org/10.1186/s13063-020-04878-y

Following publication of the original article [1], we were notified that the figure of the study design in the paper was an older, incorrect figure that did not correctly reflect randomization strategy, patient numbers, and intervention. The incorrect and correct figures are presented below.

  • Originally published figure

    figure a
  • Corrected figure

    figure b

The original article has been corrected.

Reference

  1. Vanassche T, et al. A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study. Trials. 2020;21:1005. https://doi.org/10.1186/s13063-020-04878-y.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to T. Vanassche.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vanassche, T., Engelen, M.M., Van Thillo, Q. et al. Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study. Trials 21, 1033 (2020). https://doi.org/10.1186/s13063-020-04991-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13063-020-04991-y